Prostaglandin E <sub>1</sub> : Its Effects on Hepatic Circulation in Dogs

Aida Geumei, F.A. Bashour, B.V. Swamy, A.G. Nafrawi

Pharmacology · 2008 · 99 citations · 0 references

Concepts

Abstract

The effects of intravenous, intra-arterial and intra-portal administration of prostaglandin E&lt;sub&gt;1&lt;/sub&gt; (PGE&lt;sub&gt;1&lt;/sub&gt;) on hepatic artery (HA) and portal vein (PV) flows were studied in anaestetized dogs. Intravenous administration of PGE&lt;sub&gt;1&lt;/sub&gt; (1 µg/kg) produced an increase in HA flow, PV flow and PV pressure concomitant with a significant decrease in systemic arterial pressure, whereas, the injection of the same dose of PGE&lt;sub&gt;1&lt;/sub&gt; into the portal vein caused essentially no change in PV flow, PV pressure, or systemic arterial pressure. Intra-arterial injection of PGE&lt;sub&gt;1&lt;/sub&gt; increased HA flow and decreased its resistance, with no change in systemic arterial pressure. The hepatic arterial effect of PGE&lt;sub&gt;1&lt;/sub&gt; was dose-dependent and was not abolished after β-adrenoceρtor blockade by propranolol 1 mg/kg i.v. It is concluded that PGE, possesses a direct dilator action on HA and indirectly influences the portal venous circulation.